ArticleScientific reports2017

MiRNA-21 mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and PI3K/AKT pathway.

Mao Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.